Universal Informatics · Research reading room

CD38 Deficiency Protects Mouse Retinal Ganglion Cells Through Activating the NAD+/Sirt1 Pathway in Ischemia-Reperfusion and Optic Nerve Crush Models

Pang Y, Hu H, Xu K, Cao T, Wang Z, Nie J, Zheng H, Luo H, Wang F, Xiong C, Deng KY, Xin HB, Zhang X. · Investigative ophthalmology & visual science · 2024 · Mouse retinal-injury and gene-deletion experiments

Original publication · Original publication · Original publication

Recorded summary

CD38 deletion reduced retinal injury and inflammatory responses, with evidence implicating the NAD+/Sirt1 pathway.

Recorded limitations

Gene deletion and retinal-injury models do not establish that visual exposure regulates CD38. NAD+ is a metabolite, not a gene.

Evidence and provenance

Chapter Trust Factor uses a minimum of three distinct qualifying studies. Publication records retain their own evidence and assessment.

Study design and assessment
design
Mouse retinal-injury and gene-deletion experiments
assessment
Not recorded
trust Factor
score
1
scope
Paper
status
assessed
randomized Controlled Trial
false
blinding
not-applicable
peer Reviewed
true
basis
Indexed peer-reviewed research; a qualifying randomized controlled design is not established in the reviewed record.
sources

https://pubmed.ncbi.nlm.nih.gov/38776115/ · https://doi.org/10.1167/iovs.65.5.36

review Scope
Existing publication-specific assessments and bibliographic indexing; no blanket full-text appraisal.
assessed At
2026-10-27
jadad
status
unassessed
score
Not recorded
evidence
Not recorded
Topics and recorded topic scoresNone recorded
Citation snapshot and identifiers
id
pmid-38776115
doi
10.1167/iovs.65.5.36
pmid
38776115
citation Snapshot
Not recorded
citations By Collection
vision
Not recorded
Complete approved library record
id
pmid-38776115
publication Key
Not recorded
aliases
None recorded
title
CD38 Deficiency Protects Mouse Retinal Ganglion Cells Through Activating the NAD+/Sirt1 Pathway in Ischemia-Reperfusion and Optic Nerve Crush Models
journal
Investigative ophthalmology & visual science
neurotransmitters
None recorded
year
2024
authors
Pang Y, Hu H, Xu K, Cao T, Wang Z, Nie J, Zheng H, Luo H, Wang F, Xiong C, Deng KY, Xin HB, Zhang X.
design
Mouse retinal-injury and gene-deletion experiments
kind
Journal article
identity Conflict
Not recorded
doi
10.1167/iovs.65.5.36
pmid
38776115
urls

https://pmc.ncbi.nlm.nih.gov/articles/PMC11127494/ · https://pubmed.ncbi.nlm.nih.gov/38776115/ · https://doi.org/10.1167/iovs.65.5.36

collections

vision

categories

Genetics & genomics · Molecular biomarkers

targets

CD38 · NAD+ · TNF

priority
0
quotes
None recorded
summary
CD38 deletion reduced retinal injury and inflammatory responses, with evidence implicating the NAD+/Sirt1 pathway.
limitation
Gene deletion and retinal-injury models do not establish that visual exposure regulates CD38. NAD+ is a metabolite, not a gene.
citation Count
Not recorded
paper Trust Assessment
score
1
scope
Paper
status
assessed
randomized Controlled Trial
false
blinding
not-applicable
peer Reviewed
true
basis
Indexed peer-reviewed research; a qualifying randomized controlled design is not established in the reviewed record.
sources

https://pubmed.ncbi.nlm.nih.gov/38776115/ · https://doi.org/10.1167/iovs.65.5.36

review Scope
Existing publication-specific assessments and bibliographic indexing; no blanket full-text appraisal.
assessed At
2026-10-27
citations By Collection
vision
Not recorded
topics
None recorded
journal Key
investigativeophthalmologyandvisualscience
journal Label
Investigative ophthalmology & visual science
chapter Entries
None recorded
jadad
status
unassessed
score
Not recorded
condition Evidence
None recorded
conditions
None recorded
topic Trust Scores
None recorded
full Text
status
not-indexed
retrieval Available
false

Open this publication in the interactive library